Correction
Immunosurveillance and therapy of multiple myeloma are CD226 dependent
Paper Information
Record ID:
13128
Author(s):
Journal:
Publication Date:
April 20, 2015
Retraction Date:
July 01, 2015
(10.4 years years ago)
Subjects:
Institutions:
- Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland
- School of Medicine, University of Queensland, Herston, Queensland
- Células Inflamatórias e Neoplásicas group, Universidade Federal do Paraná, Curitiba, Paraná
- Bone Marrow Transplantation, QIMR Berghofer Medical Research Institute, Herston, Queensland
- Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria
- Comprehensive Cancer Center, Mayo Clinic, Scottsdale, Arizona
- INSERM UMR 1037, Cancer Research Center of Toulouse, Toulouse
Countries:
Article Type:
Publisher:
American Society for Clinical Investigation
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Correction Details
Citations (107)
107
Total Citations100
Post-Retraction(93.5%)
2
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
5
Within 1 year
83
After 2+ years
3531
Days since retraction (latest)
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Nov 2020
1954 days after retraction
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Yuqing Cao, Xiaoyu Wang, Tianqiang Jin et al. (8 authors)
Signal Transduction and Targeted Therapy
Open Access
Published: Oct 2020
134 citations
134 citations
1947 days after retraction
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy
Marianne Weulersse, Assia Asrir, Andrea Pichler et al. (36 authors)
Immunity
Open Access
Published: Oct 2020
120 citations
120 citations
1919 days after retraction
Paper citing CEACAM1 regulates TIM-3-mediated tolerance and exh...
Unknown Authors
Unknown Journal
Published: Sep 2020
1917 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Sep 2020
1906 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jul 2020
1827 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jun 2020
1818 days after retraction
Paper citing CEACAM1 regulates TIM-3-mediated tolerance and exh...
Unknown Authors
Unknown Journal
Published: Apr 2020
1746 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Mar 2020
1713 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Feb 2020
1688 days after retraction
CD155: A Multi-Functional Molecule in Tumor Progression
Rosa Molfetta, Béatrice Zitti, Mario Lecce et al. (10 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2020
88 citations
88 citations
1674 days after retraction
NK Cells in the Tumor Microenvironment
Camille Guillerey
Advances in experimental medicine and biology
Published: Jan 2020
92 citations
92 citations
1645 days after retraction
TIGIT as an emerging immune checkpoint
Heidi Harjunpää, Camille Guillerey
Clinical & Experimental Immunology
Open Access
Published: Dec 2019
459 citations
459 citations
1625 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Sep 2019
1523 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Aug 2019
1492 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jul 2019
1485 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jun 2019
1435 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: May 2019
1423 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Apr 2019
1379 days after retraction
CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function
Deepak Mittal, Ailin Lepletier, Jason Madore et al. (19 authors)
Cancer Immunology Research
Open Access
Published: Mar 2019
94 citations
94 citations
1358 days after retraction
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Mar 2019
1342 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Dec 2018
1249 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Nov 2018
1248 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Nov 2018
1247 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Nov 2018
1237 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Oct 2018
1205 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Oct 2018
1205 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Sep 2018
1183 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Aug 2018
1154 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: May 2018
1048 days after retraction
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms
Xian-Yang Li, Indrajit Das, Ailin Lepletier et al. (17 authors)
Journal of Clinical Investigation
Open Access
Published: May 2018
101 citations
101 citations
1047 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Apr 2018
1017 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Apr 2018
1005 days after retraction
Cancer Immunosurveillance by Natural Killer Cells and Other Innate Lymphoid Cells
Camille Guillerey, Mark J. Smyth
OncoImmunology
Published: Dec 2017
4 citations
4 citations
896 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Nov 2017
883 days after retraction
Paper citing Chimeric Antigen Receptor–Modified T Cells for Acu...
Unknown Authors
Unknown Journal
Published: Nov 2017
860 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Oct 2017
849 days after retraction
Paper citing Genomic correlates of response to CTLA-4 blockade ...
Unknown Authors
Unknown Journal
Published: Oct 2017
826 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jun 2017
728 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: May 2017
670 days after retraction
Paper citing Anti-Tumor Activity of a Novel Compound-CDF Is Med...
Unknown Authors
Unknown Journal
Published: Mar 2017
623 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Feb 2017
594 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Feb 2017
589 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Feb 2017
581 days after retraction
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Dec 2016
519 days after retraction
Paper citing MicroRNAs in Cancer...
Unknown Authors
Unknown Journal
Published: Dec 2016
519 days after retraction
MGUS to myeloma: a mysterious gammopathy of underexplored significance
Madhav V. Dhodapkar
Blood
Open Access
Published: Oct 2016
153 citations
153 citations
471 days after retraction
Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy
Stephen J. Blake, William C. Dougall, John J. Miles et al. (5 authors)
Clinical Cancer Research
Open Access
Published: Sep 2016
197 citations
197 citations
440 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Sep 2016
433 days after retraction
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Aug 2016
415 days after retraction
Quick Stats
Total Citations:
107
Years Since Retraction:
10.4 years
Open Access:
Yes
Last Checked:
Never